{"nct_id":"NCT00702052","title":"Safety and Efficacy of RAD001 in Participants With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy","status":"COMPLETED","status_verified_date":"2021-04","start_date":"2008-08-22","start_date_type":"ACTUAL","primary_completion_date":"2012-04-20","primary_completion_date_type":"ACTUAL","completion_date":"2012-04-20","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}